Repligen Corporation (FRA:RGN)

Market Cap	5.38B -26.7%
Revenue (ttm)	628.77M +16.4%
Net Income	41.64M
EPS	0.73
Shares Out	n/a
PE Ratio	129.30
Forward PE	55.52
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	5
Open	97.92
Previous Close	96.98
Day's Range	97.92 - 97.92
52-Week Range	94.12 - 147.10
Beta	n/a
RSI	39.10
Earnings Date	Apr 30, 2026

About Repligen

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company’s products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spect...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1981
• Employees: 2,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: RGN

Financial Performance

Financial numbers in USD